BizNis Africa
Latest News
Nigerian Content Development and Monitoring Board signs MOU with CWC Group
The Nigerian Content Development and Monitoring Board (NCDMB) reinforces...
GIBB commits to growing women water entrepreneurs
GIBB, one of South Africa’s leading black-owned multi-disciplinary engineering...
SOUTH32 awards ZAR158 million Coal Contract to black-owned mining company
South32 has awarded a core mining contract to Broad...
Emira honoured by Investment Analysts Society for accurate financial reporting
Emira Property Fund is the winner of the Investment...
South African Auditor-General report indicates poor leadership practices
The local government audit outcomes report for the 2015-16...
Billions held in impact investments in Africa
The 2016 African Investing for Impact Barometer shows that...
How to re-define the future of Real Estate in Africa
Researchers predict that in 2030, Lagos, Cairo and Kinshasa...
Mercer – Cape Town ranks amongst 15 cheapest cities to live in globally
In a rapidly changing world, mobility has become a...
Mastercard Foundation appoints three new Board of Directors members
The MasterCard Foundation today, 21 June 2017, announced the...
Ansys revenue grew by 70% to ZAR806 million
Ansys Limited has today, 21 June 2017, announced its...

April 8th, 2017
Stephen Saad

Stephen Saad

Stephen Saad, Aspen Pharmacare Founder and CEO

Submit Press release

Fill in the form and we will deliver the car for you to test drive.

Stephen Saad is the Founder and Chief Executive Officer of Aspen Pharmacare, one of South Africa’s largest pharmaceuticals maker.

Aspen Pharmacare, traded on the Johannesburg Stock Exchange, markets generic medicines in 150 countries.

Saad became a millionaire at age 29 when he sold his share in drug business, Covan Zurich, for $3 million.

In 2012, Saad became Chairman of The Sharks, a South African rugby team.

In October 2016, Saad won the Entrepreneur of the Year award at the All Africa Business Leaders Awards gala.

One thought on “Stephen Saad

  1. Just read an article in the Times of London about Aspen healthcare’s disgusting abuse of a monopoly market position to impose massive price rises, and blackmail European healthcare systems. This involved drugs including those used to treat childhood leukaemia. Saad, like his employees is clearly a w#### of the first order. Hopefully when he gets cancer, it will be untreatable.

Leave a Reply

Ver peliculas online

Fill in your details below and we will secure you a free test drive, delivered to you.

Fill in your details below and we will secure you a free test drive, delivered to you.

%d bloggers like this: